Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6406 AL 6420

The development of new therapeutics for Alzheimer's disease

Carter MD, Simms GA, Weaver DF.

Clin Pharmacol Ther. 2010 Oct;88(4):475-86. doi: 10.1038/clpt.2010.165. Epub 2010 Sep 1.

The time has arrived to meet the challenge of Alzheimer's disease in Europe

Jones RW.

J Nutr Health Aging. 2010 Aug;14(7):523-4. doi: 10.1007/s12603-010-0262-z.

Evolving attitudes to Alzheimer's disease among the general public and caregivers in Europe: findings from the IMPACT survey

Wortmann M, Andrieu S, Mackell J, Knox S.

J Nutr Health Aging. 2010 Aug;14(7):531-6. doi: 10.1007/s12603-010-0264-x.

The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease

Farlow MR, Grossberg G, Gauthier S, Meng X, Olin JT.

Curr Med Res Opin. 2010 Oct;26(10):2441-7. doi: 10.1185/03007995.2010.513849.

Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative

Villard V, Espallergues J, Keller E, Vamvakides A, Maurice T.

J Psychopharmacol. 2011 Aug;25(8):1101-17. doi: 10.1177/0269881110379286. Epub 2010 Sep 9.

Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer's disease

Araújo JQ, Lima JA, Pinto Ada C, de Alencastro RB, Albuquerque MG.

J Mol Model. 2011 Jun;17(6):1401-12. doi: 10.1007/s00894-010-0841-2. Epub 2010 Sep 16.

Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models

Nagy B, Brennan A, Brandtmüller A, Thomas SK, Sullivan SD, Akehurst R.

Int J Geriatr Psychiatry. 2011 May;26(5):483-94. doi: 10.1002/gps.2551. Epub 2010 Sep 15.

B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review

Dangour AD, Whitehouse PJ, Rafferty K, Mitchell SA, Smith L, Hawkesworth S, Vellas B.

J Alzheimers Dis. 2010;22(1):205-24. doi: 10.3233/JAD-2010-090940.

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments

Benedict C, Frey WH 2nd, Schiöth HB, Schultes B, Born J, Hallschmid M.

Exp Gerontol. 2011 Feb-Mar;46(2-3):112-5. doi: 10.1016/j.exger.2010.08.026. Epub 2010 Sep 16.

Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients

Morillas-Ruiz JM, Rubio-Perez JM, Albaladejo MD, Zafrilla P, Parra S, Vidal-Guevara ML.

J Neurol Sci. 2010 Dec 15;299(1-2):175-8. doi: 10.1016/j.jns.2010.08.050. Epub 2010 Sep 20.

[Therapeutic strategies for Alzheimer disease based on endoplasmic reticulum stress]

Kudo T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Aug;30(4):163-8.

[Immunotherapy and Alzheimer's disease]

Arai H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Aug;30(4):173-6.

Development of the Japanese DOLOPLUS-2: a pain assessment scale for the elderly with Alzheimer's disease

Ando C, Hishinuma M.

Psychogeriatrics. 2010 Sep;10(3):131-7. doi: 10.1111/j.1479-8301.2010.00324.x. Epub 2010 Aug 28.

SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study

Maher-Edwards G, Dixon R, Hunter J, Gold M, Hopton G, Jacobs G, Hunter J, Williams P.

Int J Geriatr Psychiatry. 2011 May;26(5):536-44. doi: 10.1002/gps.2562. Epub 2010 Sep 24.

Evidence supporting technology-based interventions for people with early-stage Alzheimer's disease

Buettner LL, Yu F, Burgener SC.

J Gerontol Nurs. 2010 Oct;36(10):15-9. doi: 10.3928/00989134-20100831-01. Epub 2010 Sep 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias